Erste Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63,500
| Closed | -$833K | – | 805 |
|
|
2023
Q2 | $833K | Sell |
63,500
-35,000
| -36% | -$459K | 0.01% | 377 |
|
|
2023
Q1 | $961K | Hold |
98,500
| – | – | 0.02% | 368 |
|
|
2022
Q4 | $817K | Hold |
98,500
| – | – | 0.02% | 382 |
|
|
2022
Q3 | $552K | Hold |
98,500
| – | – | 0.01% | 410 |
|
|
2022
Q2 | $450K | Buy |
98,500
+50,000
| +103% | +$229K | 0.01% | 442 |
|
|
2022
Q1 | $468K | Buy |
+48,500
| New | +$468K | 0.01% | 442 |
|
|
2021
Q4 | – | Sell |
-26,200
| Closed | -$651K | – | 774 |
|
|
2021
Q3 | $651K | Hold |
26,200
| – | – | 0.01% | 376 |
|
|
2021
Q2 | $944K | Hold |
26,200
| – | – | 0.02% | 349 |
|
|
2021
Q1 | $785K | Sell |
26,200
-25,800
| -50% | -$773K | 0.02% | 348 |
|
|
2020
Q4 | $1.32M | Buy |
+52,000
| New | +$1.32M | 0.04% | 311 |
|